Global Urinalysis Market
A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems. A urine test includes three parts namely, visual exam, microscopic exam, and dipstick test. Its primary aim is to screen health conditions. The urinalysis is carried out as routine medical checkup, pregnancy check-up, pre-surgery preparation, or on hospital admission to treat various disorders. It may be used to screen for and/or help diagnose conditions such as a kidney disorders, urinary tract infections, liver problems, diabetes or other metabolic conditions, to name a few. Additional tests and clinical valuation are often required to further examine findings of urinalysis and finally diagnose the causes or specific features of core problems. For example, urine infection is generally identified based on results of urinalysis. Urine culture is frequently ordered as a follow-up test to recognize the bacteria that may be causing the infection.
On the basis of product type, the urinalysis market is classified into the following:
On the basis of test type, the urinalysis market is classified into following:
On the basis of end user, the urinalysis market is classified into following:
-Research Laboratories and Institutes
-Urinalysis Market Dynamics
According to Centers for Disease Control and Prevention (CDC), diabetes is one of the most common chronic diseases among humans, around 29.1 million people or 9.3% of the U.S population suffers from diabetes (2016). Increase in the prevalence of chronic diseases and geriatric population will give rise to prevention and cure for the chronic diseases, owing to the growth of urinalysis market. Emergence of portable and battery operated urinalysis devices and increase in implementation of urinalysis in emerging economic countries such as China, India and others, will create new opportunities for the urinalysis market.
Bioway Biotechnology includes Bioway Biotechnology Co., Ltd. and Yantai Bioway Biological Technology Co., Ltd. The company was founded in 1999 and specializes in R&D and production of urinalysis products. Since the establishment, the company has been committed to the research, development, production and sales of clinical diagnostic products. The main products are urine sediment analysis system, urine analyzer, urine test strip, and urine sediment analysis reagent. All products have independent core technologies and have registered a number of patents in China.